Hospital Acquired Infections Market; Global Industrial Analysis and Forecast 2027 by Pathogen Types, by Method of Treatment, by Infection Type, by Region.

Global Hospital Acquired Infections Market is expected to grow at a CAGR of 6.13% during the forecast period. Global Hospital Acquired Infections Market is expected to reach US$ 31.1 Bn. by 2027. Global Hospital Acquired infections Market To know about the Research Methodology :- Request Free Sample Report

Global Hospital Acquired infections Market Dynamics

Hospital acquired infections (HAIs) are also referred to as nosocomial infections. In this kind of infections, the patient acquires additional diseases while receiving cure for surgical or medical conditions. HAIs are probable in all settings of care, including surgical centres, hospitals, long-term care facilities such as rehabilitation facilities and nursing homes, and ambulatory clinics. HAIs are more prevalent in developing countries. Certain factors that are driving the market growth include the increase in hospital stay due to chronic diseases and surgeries, rise in the incidences of different types of hospital-acquired infections. Additionally, factor like rise in geriatric population base coupled with demand for hospital-acquired infection diagnostics from middle and low-income economies.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. However, factors such as increased microbial resistance, counterfeit and spurious products, off label usage of drugs and antiseptics, increased application of glass and ceramics in building materials, extensive market fragmentation, tough competition, penetration of generics, and loss of patent, are acting as significant restraints to the market growth. Hospital acquired infections market is segmented by infection type, method of treatment, and pathogen types. By pathogen types, the market is segmented into bacterial, fungal, and viral. Based on treatment method, the market has been segmented into Sterilants, Disinfectants and other products. Based on infection type, the market has been segmented into bloodstream infections, urinary tract infections, gastrointestinal infections, respiratory infections, and surgical site infections.

Global Hospital Acquired infections Market Regional Analysis

By geography, Hospital acquired infection is segmented into Europe, North America, APAC, Middle East & Africa, and Latin America. North America is the largest regional segment of the global hospital acquired infection control market. Moreover, the APAC and Latin American regions are expected to witness significant growth over the forecast period. Primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism in emerging countries such as China and India, rising aging population with the resultant increase in the number of chronic disease cases. The hospital acquired infection market is dominated by major players such as Becton, Dickinson and company, Advanced Sterilization Products, Belimed AG, Getinge AB, Cantel Medical Corp., STERIS Corporation, 3M Company, and others. The objective of the report is to present comprehensive analysis of Hospital Acquired Infections Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Hospital Acquired Infections Market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Hospital Acquired Infections Market make the report investor’s guide.

Scope of the Global Hospital Acquired Infections Market: Inquire before buying

Global Hospital Acquired Infections Market, by Pathogen Types

• Viral • Bacterial • Fungal

Hospital Acquired Infections Market, by Method of Treatment

• Sterilization • Chemical • Radiation

Hospital Acquired Infections Market, by Infection Type

• Urinary Tract Infections • Blood Stream Infections • Surgical Site Infections • Gastrointestinal Infections • Respiratory Infections

Hospital Acquired Infections Market, by Region

• North America • APAC • Europe • MEA& Africa • Latin America

Hospital Acquired Infections Market Major players

• Becton • Dickinson and Company (U.S.) • Steris Corporation (U.S.) • Advanced Sterilization Products • Getinge Group (Sweden) • Kimberly-Clark Corporation (U.S.) • Cantel Medical (U.S.) • BioMérieux SA (France) • Belimed AG (Switzerland) • 3M Company (U.S.) • Sterigenics International LLC. (U.S.) • Synergy Health, plc (U.K.) • Abbott • Astra Zeneca • Bayer AG • Pfizer Inc. • GlaxoSmithKline plc • Johnson and Johnson Services, Inc. • Merck and Co., Inc. • Cipla Inc. • Eli Lilly and Company • Bristol-Myers Squibb Company • F. Hoffmann-La Roche Ltd.

Global Hospital Acquired Infections Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.2. Secondary data 2.3.3. Secondary Sources 2.3.4. Primary Research 2.3.5. Data from Primary Sources 2.3.6. Breakdown of Primary Sources 3. Executive Summary: Global Hospital Acquired Infections Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Hospital Acquired Infections Market Analysis and Forecast 6.1. Global Hospital Acquired Infections Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Hospital Acquired Infections Market Analysis and Forecast, By Pathogen Types 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 7.4. Global Hospital Acquired Infections Market Size (US$ Bn) Forecast, By Pathogen Types 7.5. Global Hospital Acquired Infections Market Analysis, By Pathogen Types 7.6. Global Hospital Acquired Infections Market Attractiveness Analysis, By Pathogen Types 8. Global Hospital Acquired Infections Market Analysis and Forecast, By Method of Treatment 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 8.4. Global Hospital Acquired Infections Market Size (US$ Bn) Forecast, By Method of Treatment 8.5. Global Hospital Acquired Infections Market Analysis, By Method of Treatment 8.6. Global Hospital Acquired Infections Market Attractiveness Analysis, By Method of Treatment 9. Global Hospital Acquired Infections Market Analysis and Forecast, by Infection Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Hospital Acquired Infections Market Value Share Analysis, by Infection Type 9.4. Global Hospital Acquired Infections Market Size (US$ Bn) Forecast, by Infection Type 9.5. Global Hospital Acquired Infections Market Analysis, by Infection Type 9.6. Global Hospital Acquired Infections Market Attractiveness Analysis, by Infection Type 10. Global Hospital Acquired Infections Market Analysis, by Region 10.1. Global Hospital Acquired Infections Market Value Share Analysis, by Region 10.2. Global Hospital Acquired Infections Market Size (US$ Bn) Forecast, by Region 10.3. Global Hospital Acquired Infections Market Attractiveness Analysis, by Region 11. North America Hospital Acquired Infections Market Analysis 11.1. Key Findings 11.2. North America Hospital Acquired Infections Market Overview 11.3. North America Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 11.4. North America Hospital Acquired Infections Market Forecast, By Pathogen Types 11.4.1. Healthcare Provider Solutions 11.4.2. Healthcare Payer Solutions 11.4.3. HCIT Outsourcing Services 11.5. North America Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 11.6. North America Hospital Acquired Infections Market Forecast, By Method of Treatment 11.6.1. Sterilization 11.6.2. Chemical 11.6.3. Radiation 11.7. North America Hospital Acquired Infections Market Value Share Analysis, by Infection Type 11.8. North America Hospital Acquired Infections Market Forecast, by Infection Type 11.8.1. Urinary Tract Infections 11.8.2. Blood Stream Infections 11.8.3. Surgical Site Infections 11.8.4. Gastrointestinal Infections 11.8.5. Respiratory Infections 11.9. North America Hospital Acquired Infections Market Value Share Analysis, by Country 11.10. North America Hospital Acquired Infections Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Hospital Acquired Infections Market Analysis, by Country 11.12. U.S. Hospital Acquired Infections Market Forecast, By Pathogen Types 11.12.1. Viral 11.12.2. Bacterial 11.12.3. Fungal 11.13. U.S. Hospital Acquired Infections Market Forecast, By Method of Treatment 11.13.1. Sterilization 11.13.2. Chemical 11.13.3. Radiation 11.14. U.S. Hospital Acquired Infections Market Forecast, by Infection Type 11.14.1. Healthcare Payers 11.14.2. Healthcare Providers 11.15. Canada Hospital Acquired Infections Market Forecast, By Pathogen Types 11.15.1. Urinary Tract Infections 11.15.2. Blood Stream Infections 11.15.3. Surgical Site Infections 11.15.4. Gastrointestinal Infections 11.15.5. Respiratory Infections 11.16. Canada Hospital Acquired Infections Market Forecast, By Method of Treatment 11.16.1. Sterilization 11.16.2. Chemical 11.16.3. Radiation 11.17. Canada Hospital Acquired Infections Market Forecast, by Infection Type 11.17.1. Urinary Tract Infections 11.17.2. Blood Stream Infections 11.17.3. Surgical Site Infections 11.17.4. Gastrointestinal Infections 11.17.5. Respiratory Infections 11.18. North America Hospital Acquired Infections Market Attractiveness Analysis 11.18.1. By Pathogen Types 11.18.2. By Method of Treatment 11.18.3. By Infection Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Hospital Acquired Infections Market Analysis 12.1. Key Findings 12.2. Europe Hospital Acquired Infections Market Overview 12.3. Europe Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 12.4. Europe Hospital Acquired Infections Market Forecast, By Pathogen Types 12.4.1. Viral 12.4.2. Bacterial 12.4.3. Fungal 12.5. Europe Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 12.6. Europe Hospital Acquired Infections Market Forecast, By Method of Treatment 12.6.1. Sterilization 12.6.2. Chemical 12.6.3. Radiation 12.7. Europe Hospital Acquired Infections Market Value Share Analysis, by Infection Type 12.8. Europe Hospital Acquired Infections Market Forecast, by Infection Type 12.8.1. Urinary Tract Infections 12.8.2. Blood Stream Infections 12.8.3. Surgical Site Infections 12.8.4. Gastrointestinal Infections 12.8.5. Respiratory Infections 12.9. Europe Hospital Acquired Infections Market Value Share Analysis, by Country 12.10. Europe Hospital Acquired Infections Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Hospital Acquired Infections Market Analysis, by Country 12.12. Germany Hospital Acquired Infections Market Forecast, By Pathogen Types 12.12.1. Viral 12.12.2. Bacterial 12.12.3. Fungal 12.13. Germany Hospital Acquired Infections Market Forecast, By Method of Treatment 12.13.1. Sterilization 12.13.2. Chemical 12.13.3. Radiation 12.14. Germany Hospital Acquired Infections Market Forecast, by Infection Type 12.14.1. Healthcare Payers 12.14.2. Healthcare Providers 12.15. U.K. Hospital Acquired Infections Market Forecast, By Pathogen Types 12.15.1. Urinary Tract Infections 12.15.2. Blood Stream Infections 12.15.3. Surgical Site Infections 12.15.4. Gastrointestinal Infections 12.15.5. Respiratory Infections 12.16. U.K. Hospital Acquired Infections Market Forecast, By Method of Treatment 12.16.1. Sterilization 12.16.2. Chemical 12.16.3. Radiation 12.17. U.K. Hospital Acquired Infections Market Forecast, by Infection Type 12.17.1. Urinary Tract Infections 12.17.2. Blood Stream Infections 12.17.3. Surgical Site Infections 12.17.4. Gastrointestinal Infections 12.17.5. Respiratory Infections 12.18. France Hospital Acquired Infections Market Forecast, By Pathogen Types 12.18.1. Viral 12.18.2. Bacterial 12.18.3. Fungal 12.19. France Hospital Acquired Infections Market Forecast, By Method of Treatment 12.19.1. Sterilization 12.19.2. Chemical 12.19.3. Radiation 12.20. France Hospital Acquired Infections Market Forecast, by Infection Type 12.20.1. Urinary Tract Infections 12.20.2. Blood Stream Infections 12.20.3. Surgical Site Infections 12.20.4. Gastrointestinal Infections 12.20.5. Respiratory Infections 12.21. Italy Hospital Acquired Infections Market Forecast, By Pathogen Types 12.21.1. Viral 12.21.2. Bacterial 12.21.3. Fungal 12.22. Italy Hospital Acquired Infections Market Forecast, By Method of Treatment 12.22.1. Sterilization 12.22.2. Chemical 12.22.3. Radiation 12.23. Italy Hospital Acquired Infections Market Forecast, by Infection Type 12.23.1. Urinary Tract Infections 12.23.2. Blood Stream Infections 12.23.3. Surgical Site Infections 12.23.4. Gastrointestinal Infections 12.23.5. Respiratory Infections 12.24. Spain Hospital Acquired Infections Market Forecast, By Pathogen Types 12.24.1. Viral 12.24.2. Bacterial 12.24.3. Fungal 12.25. Spain Hospital Acquired Infections Market Forecast, By Method of Treatment 12.25.1. Sterilization 12.25.2. Chemical 12.25.3. Radiation 12.26. Spain Hospital Acquired Infections Market Forecast, by Infection Type 12.26.1. Urinary Tract Infections 12.26.2. Blood Stream Infections 12.26.3. Surgical Site Infections 12.26.4. Gastrointestinal Infections 12.26.5. Respiratory Infections 12.27. Rest of Europe Hospital Acquired Infections Market Forecast, By Pathogen Types 12.27.1. Viral 12.27.2. Bacterial 12.27.3. Fungal 12.28. Rest of Europe Hospital Acquired Infections Market Forecast, By Method of Treatment 12.28.1. Sterilization 12.28.2. Chemical 12.28.3. Radiation 12.29. Rest of Europe Hospital Acquired Infections Market Forecast, by Infection Type 12.29.1. Urinary Tract Infections 12.29.2. Blood Stream Infections 12.29.3. Surgical Site Infections 12.29.4. Gastrointestinal Infections 12.29.5. Respiratory Infections 12.30. Europe Hospital Acquired Infections Market Attractiveness Analysis 12.30.1. By Pathogen Types 12.30.2. By Method of Treatment 12.30.3. By Infection Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Hospital Acquired Infections Market Analysis 13.1. Key Findings 13.2. Asia Pacific Hospital Acquired Infections Market Overview 13.3. Asia Pacific Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 13.4. Asia Pacific Hospital Acquired Infections Market Forecast, By Pathogen Types 13.4.1. Viral 13.4.2. Bacterial 13.4.3. Fungal 13.5. Asia Pacific Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 13.6. Asia Pacific Hospital Acquired Infections Market Forecast, By Method of Treatment 13.6.1. Sterilization 13.6.2. Chemical 13.6.3. Radiation 13.7. Asia Pacific Hospital Acquired Infections Market Value Share Analysis, by Infection Type 13.8. Asia Pacific Hospital Acquired Infections Market Forecast, by Infection Type 13.8.1. Urinary Tract Infections 13.8.2. Blood Stream Infections 13.8.3. Surgical Site Infections 13.8.4. Gastrointestinal Infections 13.8.5. Respiratory Infections 13.9. Asia Pacific Hospital Acquired Infections Market Value Share Analysis, by Country 13.10. Asia Pacific Hospital Acquired Infections Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Hospital Acquired Infections Market Analysis, by Country 13.12. China Hospital Acquired Infections Market Forecast, By Pathogen Types 13.12.1. Viral 13.12.2. Bacterial 13.12.3. Fungal 13.13. China Hospital Acquired Infections Market Forecast, By Method of Treatment 13.13.1. Sterilization 13.13.2. Chemical 13.13.3. Radiation 13.14. China Hospital Acquired Infections Market Forecast, by Infection Type 13.14.1. Urinary Tract Infections 13.14.2. Blood Stream Infections 13.14.3. Surgical Site Infections 13.14.4. Gastrointestinal Infections 13.14.5. Respiratory Infections 13.15. India Hospital Acquired Infections Market Forecast, By Pathogen Types 13.15.1. Viral 13.15.2. Bacterial 13.15.3. Fungal 13.16. India Hospital Acquired Infections Market Forecast, By Method of Treatment 13.16.1. Sterilization 13.16.2. Chemical 13.16.3. Radiation 13.17. India Hospital Acquired Infections Market Forecast, by Infection Type 13.17.1. Urinary Tract Infections 13.17.2. Blood Stream Infections 13.17.3. Surgical Site Infections 13.17.4. Gastrointestinal Infections 13.17.5. Respiratory Infections 13.18. Japan Hospital Acquired Infections Market Forecast, By Pathogen Types 13.18.1. Viral 13.18.2. Bacterial 13.18.3. Fungal 13.19. Japan Hospital Acquired Infections Market Forecast, By Method of Treatment 13.19.1. Sterilization 13.19.2. Chemical 13.19.3. Radiation 13.20. Japan Hospital Acquired Infections Market Forecast, by Infection Type 13.20.1. Urinary Tract Infections 13.20.2. Blood Stream Infections 13.20.3. Surgical Site Infections 13.20.4. Gastrointestinal Infections 13.20.5. Respiratory Infections 13.21. ASEAN Hospital Acquired Infections Market Forecast, By Pathogen Types 13.21.1. Viral 13.21.2. Bacterial 13.21.3. Fungal 13.22. ASEAN Hospital Acquired Infections Market Forecast, By Method of Treatment 13.22.1. Sterilization 13.22.2. Chemical 13.22.3. Radiation 13.23. ASEAN Hospital Acquired Infections Market Forecast, by Infection Type 13.23.1. Urinary Tract Infections 13.23.2. Blood Stream Infections 13.23.3. Surgical Site Infections 13.23.4. Gastrointestinal Infections 13.23.5. Respiratory Infections 13.24. Rest of Asia Pacific Hospital Acquired Infections Market Forecast, By Pathogen Types 13.24.1. Viral 13.24.2. Bacterial 13.24.3. Fungal 13.25. Rest of Asia Pacific Hospital Acquired Infections Market Forecast, By Method of Treatment 13.25.1. Sterilization 13.25.2. Chemical 13.25.3. Radiation 13.26. Rest of Asia Pacific Hospital Acquired Infections Market Forecast, by Infection Type 13.26.1. Urinary Tract Infections 13.26.2. Blood Stream Infections 13.26.3. Surgical Site Infections 13.26.4. Gastrointestinal Infections 13.26.5. Respiratory Infections 13.27. Asia Pacific Hospital Acquired Infections Market Attractiveness Analysis 13.27.1. By Pathogen Types 13.27.2. By Method of Treatment 13.27.3. By Infection Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Hospital Acquired Infections Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Hospital Acquired Infections Market Overview 14.3. Middle East & Africa Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 14.4. Middle East & Africa Hospital Acquired Infections Market Forecast, By Pathogen Types 14.4.1. Viral 14.4.2. Bacterial 14.4.3. Fungal 14.5. Middle East & Africa Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 14.6. Middle East & Africa Hospital Acquired Infections Market Forecast, By Method of Treatment 14.6.1. Sterilization 14.6.2. Chemical 14.6.3. Radiation 14.7. Middle East & Africa Hospital Acquired Infections Market Value Share Analysis, by Infection Type 14.8. Middle East & Africa Hospital Acquired Infections Market Forecast, by Infection Type 14.8.1. Urinary Tract Infections 14.8.2. Blood Stream Infections 14.8.3. Surgical Site Infections 14.8.4. Gastrointestinal Infections 14.8.5. Respiratory Infections 14.9. Middle East & Africa Hospital Acquired Infections Market Value Share Analysis, by Country 14.10. Middle East & Africa Hospital Acquired Infections Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Hospital Acquired Infections Market Analysis, by Country 14.12. GCC Hospital Acquired Infections Market Forecast, By Pathogen Types 14.12.1. Viral 14.12.2. Bacterial 14.12.3. Fungal 14.13. GCC Hospital Acquired Infections Market Forecast, By Method of Treatment 14.13.1. Sterilization 14.13.2. Chemical 14.13.3. Radiation 14.14. GCC Hospital Acquired Infections Market Forecast, by Infection Type 14.14.1. Urinary Tract Infections 14.14.2. Blood Stream Infections 14.14.3. Surgical Site Infections 14.14.4. Gastrointestinal Infections 14.14.5. Respiratory Infections 14.15. South Africa Hospital Acquired Infections Market Forecast, By Pathogen Types 14.15.1. Viral 14.15.2. Bacterial 14.15.3. Fungal 14.16. South Africa Hospital Acquired Infections Market Forecast, By Method of Treatment 14.16.1. Sterilization 14.16.2. Chemical 14.16.3. Radiation 14.17. South Africa Hospital Acquired Infections Market Forecast, by Infection Type 14.17.1. Urinary Tract Infections 14.17.2. Blood Stream Infections 14.17.3. Surgical Site Infections 14.17.4. Gastrointestinal Infections 14.17.5. Respiratory Infections 14.18. Rest of Middle East & Africa Hospital Acquired Infections Market Forecast, By Pathogen Types 14.18.1. Viral 14.18.2. Bacterial 14.18.3. Fungal 14.19. Rest of Middle East & Africa Hospital Acquired Infections Market Forecast, By Method of Treatment 14.19.1. Sterilization 14.19.2. Chemical 14.19.3. Radiation 14.20. Rest of Middle East & Africa Hospital Acquired Infections Market Forecast, by Infection Type 14.20.1. Urinary Tract Infections 14.20.2. Blood Stream Infections 14.20.3. Surgical Site Infections 14.20.4. Gastrointestinal Infections 14.20.5. Respiratory Infections 14.21. Middle East & Africa Hospital Acquired Infections Market Attractiveness Analysis 14.21.1. By Pathogen Types 14.21.2. By Method of Treatment 14.21.3. By Infection Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Hospital Acquired Infections Market Analysis 15.1. Key Findings 15.2. South America Hospital Acquired Infections Market Overview 15.3. South America Hospital Acquired Infections Market Value Share Analysis, By Pathogen Types 15.4. South America Hospital Acquired Infections Market Forecast, By Pathogen Types 15.4.1. Viral 15.4.2. Bacterial 15.4.3. Fungal 15.5. South America Hospital Acquired Infections Market Value Share Analysis, By Method of Treatment 15.6. South America Hospital Acquired Infections Market Forecast, By Method of Treatment 15.6.1. Sterilization 15.6.2. Chemical 15.6.3. Radiation 15.7. South America Hospital Acquired Infections Market Value Share Analysis, by Infection Type 15.8. South America Hospital Acquired Infections Market Forecast, by Infection Type 15.8.1. Urinary Tract Infections 15.8.2. Blood Stream Infections 15.8.3. Surgical Site Infections 15.8.4. Gastrointestinal Infections 15.8.5. Respiratory Infections 15.9. South America Hospital Acquired Infections Market Value Share Analysis, by Country 15.10. South America Hospital Acquired Infections Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Hospital Acquired Infections Market Analysis, by Country 15.12. Brazil Hospital Acquired Infections Market Forecast, By Pathogen Types 15.12.1. Viral 15.12.2. Bacterial 15.12.3. Fungal 15.13. Brazil Hospital Acquired Infections Market Forecast, By Method of Treatment 15.13.1. Sterilization 15.13.2. Chemical 15.13.3. Radiation 15.14. Brazil Hospital Acquired Infections Market Forecast, by Infection Type 15.14.1. Urinary Tract Infections 15.14.2. Blood Stream Infections 15.14.3. Surgical Site Infections 15.14.4. Gastrointestinal Infections 15.14.5. Respiratory Infections 15.15. Mexico Hospital Acquired Infections Market Forecast, By Pathogen Types 15.15.1. Viral 15.15.2. Bacterial 15.15.3. Fungal 15.16. Mexico Hospital Acquired Infections Market Forecast, By Method of Treatment 15.16.1. Sterilization 15.16.2. Chemical 15.16.3. Radiation 15.17. Mexico Hospital Acquired Infections Market Forecast, by Infection Type 15.17.1. Urinary Tract Infections 15.17.2. Blood Stream Infections 15.17.3. Surgical Site Infections 15.17.4. Gastrointestinal Infections 15.17.5. Respiratory Infections 15.18. Rest of South America Hospital Acquired Infections Market Forecast, By Pathogen Types 15.18.1. Viral 15.18.2. Bacterial 15.18.3. Fungal 15.19. Rest of South America Hospital Acquired Infections Market Forecast, By Method of Treatment 15.19.1. Sterilization 15.19.2. Chemical 15.19.3. Radiation 15.20. Rest of South America Hospital Acquired Infections Market Forecast, by Infection Type 15.20.1. Urinary Tract Infections 15.20.2. Blood Stream Infections 15.20.3. Surgical Site Infections 15.20.4. Gastrointestinal Infections 15.20.5. Respiratory Infections 15.21. South America Hospital Acquired Infections Market Attractiveness Analysis 15.21.1. By Pathogen Types 15.21.2. By Method of Treatment 15.21.3. By Infection Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Becton 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Dickinson and Company (U.S.) 16.3.3. Steris Corporation (U.S.) 16.3.4. Advanced Sterilization Products 16.3.5. Getinge Group (Sweden) 16.3.6. Kimberly-Clark Corporation (U.S.) 16.3.7. Cantel Medical (U.S.) 16.3.8. BioMérieux SA (France) 16.3.9. Belimed AG (Switzerland) 16.3.10. 3M Company (U.S.) 16.3.11. Sterigenics International LLC. (U.S.) 16.3.12. Synergy Health, plc (U.K.) 16.3.13. Abbott 16.3.14. Astra Zeneca 16.3.15. Bayer AG 16.3.16. Pfizer Inc. 16.3.17. GlaxoSmithKline plc 16.3.18. Johnson and Johnson Services, Inc. 16.3.19. Merck and Co., Inc. 16.3.20. Cipla Inc. 17. Primary Key Insights

About This Report

Report ID 36923
Category Healthcare
Published Date Nov 2019
Updated Date Dec 2020
Contact Us